Strategies for the prevention of cytomegalovirus infection and disease in pediatric liver transplantation recipients

Andrew L. Campbell, Betsy Herold

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Cytomegalovirus (CMV) is the most common opportunistic infection following solid organ transplantation. Prevention and management of CMV infection has assumed a higher priority as transplantation has become a frequent treatment for many congenital and acquired disorders, as more potent immunosuppressive agents have become available, new molecular and virologic assays to detect CMV have made their way from research to clinical laboratories and new antiviral medications and biologics have been developed. Management strategies are diverse; however, there are little or no data from large controlled pediatric trials demonstrating the superiority of any particular approach. This review outlines the current strategies employed to prevent CMV infection and disease and summarizes the strengths and limitations of each regimen to guide clinicians in the selection of the optimal preventative approach.

Original languageEnglish (US)
Pages (from-to)619-627
Number of pages9
JournalPediatric Transplantation
Volume8
Issue number6
DOIs
StatePublished - Dec 2004
Externally publishedYes

Fingerprint

Cytomegalovirus Infections
Cytomegalovirus
Liver Transplantation
Pediatrics
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Opportunistic Infections
Organ Transplantation
Immunosuppressive Agents
Biological Products
Antiviral Agents
Transplantation
Research
Therapeutics

Keywords

  • Cytomegalovirus
  • Liver transplant
  • Pre-emptive therapy
  • Solid organ transplantation
  • Universal prophylaxis

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Transplantation

Cite this

Strategies for the prevention of cytomegalovirus infection and disease in pediatric liver transplantation recipients. / Campbell, Andrew L.; Herold, Betsy.

In: Pediatric Transplantation, Vol. 8, No. 6, 12.2004, p. 619-627.

Research output: Contribution to journalArticle

@article{02b2015c1dd44fbaba6fd26d8d9d9cf6,
title = "Strategies for the prevention of cytomegalovirus infection and disease in pediatric liver transplantation recipients",
abstract = "Cytomegalovirus (CMV) is the most common opportunistic infection following solid organ transplantation. Prevention and management of CMV infection has assumed a higher priority as transplantation has become a frequent treatment for many congenital and acquired disorders, as more potent immunosuppressive agents have become available, new molecular and virologic assays to detect CMV have made their way from research to clinical laboratories and new antiviral medications and biologics have been developed. Management strategies are diverse; however, there are little or no data from large controlled pediatric trials demonstrating the superiority of any particular approach. This review outlines the current strategies employed to prevent CMV infection and disease and summarizes the strengths and limitations of each regimen to guide clinicians in the selection of the optimal preventative approach.",
keywords = "Cytomegalovirus, Liver transplant, Pre-emptive therapy, Solid organ transplantation, Universal prophylaxis",
author = "Campbell, {Andrew L.} and Betsy Herold",
year = "2004",
month = "12",
doi = "10.1111/j.1399-3046.2004.00242.x",
language = "English (US)",
volume = "8",
pages = "619--627",
journal = "Pediatric Transplantation",
issn = "1397-3142",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Strategies for the prevention of cytomegalovirus infection and disease in pediatric liver transplantation recipients

AU - Campbell, Andrew L.

AU - Herold, Betsy

PY - 2004/12

Y1 - 2004/12

N2 - Cytomegalovirus (CMV) is the most common opportunistic infection following solid organ transplantation. Prevention and management of CMV infection has assumed a higher priority as transplantation has become a frequent treatment for many congenital and acquired disorders, as more potent immunosuppressive agents have become available, new molecular and virologic assays to detect CMV have made their way from research to clinical laboratories and new antiviral medications and biologics have been developed. Management strategies are diverse; however, there are little or no data from large controlled pediatric trials demonstrating the superiority of any particular approach. This review outlines the current strategies employed to prevent CMV infection and disease and summarizes the strengths and limitations of each regimen to guide clinicians in the selection of the optimal preventative approach.

AB - Cytomegalovirus (CMV) is the most common opportunistic infection following solid organ transplantation. Prevention and management of CMV infection has assumed a higher priority as transplantation has become a frequent treatment for many congenital and acquired disorders, as more potent immunosuppressive agents have become available, new molecular and virologic assays to detect CMV have made their way from research to clinical laboratories and new antiviral medications and biologics have been developed. Management strategies are diverse; however, there are little or no data from large controlled pediatric trials demonstrating the superiority of any particular approach. This review outlines the current strategies employed to prevent CMV infection and disease and summarizes the strengths and limitations of each regimen to guide clinicians in the selection of the optimal preventative approach.

KW - Cytomegalovirus

KW - Liver transplant

KW - Pre-emptive therapy

KW - Solid organ transplantation

KW - Universal prophylaxis

UR - http://www.scopus.com/inward/record.url?scp=11144242204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11144242204&partnerID=8YFLogxK

U2 - 10.1111/j.1399-3046.2004.00242.x

DO - 10.1111/j.1399-3046.2004.00242.x

M3 - Article

VL - 8

SP - 619

EP - 627

JO - Pediatric Transplantation

JF - Pediatric Transplantation

SN - 1397-3142

IS - 6

ER -